nxp800
cancer therapeutics crc,nuvectis pharma
['nxp800']
$nvct nuvectis pharma recaps poster presentation highlights for nxp800's activity in cholangiocarcinoma pdx models at the 2023 american association for cancer research ("aacr") annual meeting 45 seconds delayed.
Democratizing insights.

Not investment advice.